Drug Detail
Information about Bezuclastinib
Generic Name |
Bezuclastinib | |
|---|---|---|
IND |
CGT9486 | |
Brand Name (US) |
||
Manufacturer |
Cogent Bioscience | |
Drug Type |
||
Delivery |
Oral | |
Approval Status |
Phase 2 | |
Indications |
ASM | |
Overall Strategy |
KIT Protein Based | |
Strategy |
Block KIT | |
Drug Category |
KIT inhibitor | |
Previously PLX9486
Links |
|
Trials of this drug |
|
|
Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors |
Trial results |
|
Search for this drug/combination in: